Ovarian Sertoli–Leydig cell tumors: MRI findings and pathological correlation

Journal of Ovarian Research

Li Wang³  Xue-Zhen Wang²  Guo-Fu Zhang²  Jin-Wei Qiang¹  Shu-Hui Zhao¹  Song-Qi Cai¹ 

[1] Department of Radiology, Jinshan Hospital, Shanghai Medical College, Fudan University, Shanghai 201508, China;Department of Radiology, Obsterics & Gynecology Hospital, Shanghai Medical College, Fudan University, Shanghai 200011, China;Department of Pathology, Jinshan Hospital, Shanghai Medical College, Fudan University, Shanghai 201508, China

关键词: Pathology;    Magnetic resonance imaging;    Sertoli-Leydig cell tumors;    Ovary;   

Others  :  805249
DOI  :  10.1186/1757-2215-6-73

 received in 2013-07-15, accepted in 2013-10-21,  发布年份 2013

【 摘 要 】

Background

To investigate the magnetic resonance imaging (MRI) characteristics of ovarian Sertoli-Leydig cell tumors (SLCT).

Methods

The clinical, MRI and pathological findings of five cases of SLCT were reviewed retrospectively. MRI appearances of tumors including laterality, shape and size, architecture, wall, septa and vegetation, signal intensity and contrast-enhancement pattern were evaluated and correlated with pathological findings.

Results

Two tumors were solid which appeared as low signal intensity on T1-weighted imaging (T1WI) and moderate on T2-weighted imaging (T2WI) with multiple small cysts in one of them. The remaining three SLCT were multilocular cystic with the irregularly thickened wall and septa, and with solid area and mural nodules in one of them. The cystic components had the same signal intensity as urine. All the solid components were intensely enhanced after administration of contrast medium. All five tumors were pathologically intermediate differentiation and at FIGO stage I.

Conclusions

SLCT demonstrate variable MRI morphological appearances. However, the irregularly thickened wall and septa, the moderate T2WI signal intensity and obvious enhancement in the solid components are three MRI features.

【 授权许可】

   
2013 Cai et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Tavassoli FA, Mooney E, Gersell DJ, McCluggage WG, Konishi I, Fujii S, Kiyokawa T, Schwartz P, Kubik-Huch RA, Roth LM: Sex cord-stromal tumors. pathology and genetics of tumors of the breast and female genital organs. Lyon: International Agency for Research on Cancer (IARC); 2003:153-156.
• [2]Young RH, Scully RE: Ovarian Sertoli-Leydig cell tumors - a clinicopathological analysis of 207 cases. Am J Sur Pathol 1985, 9:543-569.
• [3]Gui T, Cao D, Shen K, Yang J, Zhang Y, Yu Q, Wan X, Xiang Y, Xiao Y, Guo L: A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors. Gynecol Oncol 2012, 127:384-389.
• [4]Niedziela M: Virilizing ovarian tumor in a 14-year-old female with a prior familial multinodular goiter. Pediatr Blood Cancer 2008, 51:543-545.
• [5]Azuma A, Koyama T, Mikami Y, Tamai K, Fujimoto K, Morisawa N, Nagano F, Yoshioka S, Togashi K: A case of Sertoli-Leydig cell tumour of the ovary with a multilocular cystic appearance on CT and MR imaging. Pediatr Radiol 2008, 38:898-901.
• [6]Outwater EK, Marchetto B, Wagner BJ: Virilizing tumors of the ovary: imaging features. Ultrasound Obstet Gynecol 2000, 15:365-371.
• [7]Dolge OG: Typing of Ovarian Tumors (International Histological Classification of Tumours, No.9). Geneva: World Health Organization; 1973.
• [8]Tanaka YO, Tsunoda H, Kitagawa Y, Ueno T, Yoshikawa H, Saida Y: Functioning ovarian tumors: direct and indirect findings at MR imaging. Radiographics 2004, 24(Suppl 1):147-166.
• [9]Shi JL, Guo LN, Lang JH: Advances in Sertoli-Leydig cell tumour of the ovary. Zhonghua Bing Li Xue Za Zhi 2008, 37:631-633.
• [10]Choong CS, Fuller PJ, Chu S, Jeske Y, Bowling F, Brown R, Borzi P, Balazs ND, Suppiah R, Cotterill AM, Payton D, Robertson DM, Burger HG: Sertoli-Leydig cell tumor of the ovary, a rare cause of precocious puberty in a 12-month-old infant. J Clin Endocrinol Metab 2002, 87:49-56.
• [11]Caringella A, Loizzi V, Resta L, Ferreri R, Loverro G: A case of Sertoli-Leydig cell tumor in a postmenopausal woman. Int J Gynecol Cancer 2006, 16:435-438.
• [12]Zhang M, Cheung MK, Shin JY, Kapp DS, Husain A, Teng NN, Berek JS, Osann K, Chan JK: Prognostic factors responsible for survival in sex cord stromal tumors of the ovary-an analysis of 376 women. Gynecol Oncol 2007, 104:396-400.
• [13]Zaloudek C, Norris HJ: Sertoli-Leydig tumors of the ovary. A clinicopathologic study of 64 intermediate and poorly differentiated neoplasms. Am J Surg Pathol 1984, 8:405-418.
• [14]Young RH, Prat J, Scully RE: Ovarian Sertoli-Leydig cell tumors with heterologous elements. I. Gastrointestinal epithelium and carcinoid: a clinicopathologic analysis of thirty-six cases. Cancer 1982, 50:2448-2456.
• [15]Mooney EE, Nogales FF, Bergeron C, Tavassoli FA: Retiform Sertoli-Leydig cell tumours: clinical, morphological and immunohistochemical findings. Histology 2002, 41:110-117.
• [16]Young RH: Sertoli-Leydig cell tumors of the ovary - review with emphasis on histologic aspects and unusual variants. Gynecol Oncol 1993, 12:141-147.
• [17]Jung SE, Lee JM, Rha SE, Byun JY, Jung JI, Hahn ST: CT and MR Imaging of ovarian tumors with emphasis on differential diagnosis. Radiographics 2002, 22:1305-1325.
• [18]Jung SE, Rha SE, Lee JM, Park SY, Oh SN, Cho KS, Lee EJ, Byun JY, Hahn ST: CT and MRI findings of sex cord-stromal tumor of the ovary. AJR Am J Roentgenol 2005, 185:207-215.
• [19]Ghossain MA, Buy JN, Ligneres C, Bazot M, Hassen K, Malbec L, Hugol D, Truc JB, Decroix Y, Poitout P: Epithelial tumors of the ovary: comparison of MR and CT findings. Radiology 1991, 181:863-870.